User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 23 results.
    • Journal article
    Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trial
    Jehn, U. Suciu, Stefan[UCL] Thomas, X. Lefrere, F. Muus, P. Berneman, Z. Marie, J-P Adamo, F. Fillet, G. Nobile, F. Ricciuti, F. Leone, G. Rizzoli, V. Montanaro, M. Beeldens, F. Fazi, P. Mandelli, F. Willemze, R. de Witte, T. Amadori, S. (2006) Leukemia — Vol. 20, no. 10, p. 1723-1730 (2006)
    • Speech
    Allogeneic SCT planned in CR-1 after intensive chemotherapy in patients with bad prognosis MDS results in better outcome in the intermediate/high-risk cytogenetic group: a study by the EORTC, EBMT, SAKK, HOVON and GIMEMA Leukemia Groups
    de Witte, T. Hagemeijer, Anne Suciu, Stefan[UCL] Belhabri, A Delforge, Michel Aul, C Aivado, M Selleslag, D. Schouten, H Ferrant, Augustin[UCL] Biersack, H Amadori, S. Muus, P. Jehn, U. Beeldens, F. Jansen, J Hellstrom-Lindberg, P Ossenkoppele, G Gratwohl, A. Marie, JP Willemze, R. (2006) 32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group — Hamburg (Germany)
    • Journal article
    The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)
    Oosterveld, M Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Verhoef, G. Labar, B. Belhabri, A Aul, C Selleslag, D. Wijermans, P Mandelli, F. Amadori, S. Jehn, U. Muus, P. Zittoun, R Hess, U. Anak, O Beeldens, F. Willemze, R. de Witte, T. (2003) Leukemia — Vol. 17, no. 5, p. 859-868 (2003)
    • Journal article
    Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CRI): an intention-to-treat analysis of the EORTC/GIMEMA AML-10 trial
    Suciu, Stefan[UCL] Mandelli, F. de Witte, T. Zittoun, R Gallo, E Labar, B. De Rosa, G Belhabri, A Giustolisi, R Delarue, R. Liso, V Mirto, S Leone, G. Bourhis, JH Fioritoni, G Jehn, U. Amadori, S. Fazi, P. Hagemeijer, Anne[UCL] Willemze, R. (2003) Blood — Vol. 102, no. 4, p. 1232-1240 (2003)
    • Journal article
    Does adjuvant interferon-alpha for high-risk melanoma provide a worthwhile benefit? A meta-analysis of the randomised trials
    Wheatley, K Ives, N Hancock, B Gore, M Eggermont, A Suciu, Stefan[UCL] (2003) Cancer Treatment Reviews — Vol. 29, no. 4, p. 241-252 (2003)
    • Journal article
    The stem cell mobilizing capacity of patients with acute myeloid leukemia in complete remission correlates with relapse risk: results of the EORTC-GIMEMA AML-10 trial
    Keating, S Suciu, Stefan[UCL] de Witte, T. Zittoun, R Mandelli, F. Belhabri, A Amadori, S. Fibbe, W Gallo, E Fillet, G. Varet, B. Meloni, G Hagemeijer, Anne[UCL] Fazi, P. Solbu, G Willemze, R. (2003) Leukemia — Vol. 17, no. 1, p. 60-67 (2003)
    • Journal article
    Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors
    Oosterveld, M Ferrant, Augustin[UCL] Muus, P. Suciu, Stefan[UCL] Koller, C Verhoef, G. Labar, B. Wijermans, P Aul, C Fiere, D. Selleslag, D. Willemze, R. Gratwohl, A. Mandelli, F. Cortes, J de Witte, T. Estey, E (2002) Leukemia — Vol. 16, no. 9, p. 1615-1621 (2002)
    • Speech
    Adjuvant trial in melanoma patients comparing rIFN-alpha to rIFN-gamma to Iscador to a control group after curative resection of high risk primary (>= 3MM) or regional lymphnode metastasis (EORTC 18871)
    Kleeberg, UR Brocker, EB Lejeune, F. Chartier, C Egger, C Marsden, J Ruiter, D. Suciu, Stefan[UCL] (1999) —
    • Journal article
    The Value of Bmt in Aml Patients in 1st Remission - a Statisticians Viewpoint
    Suciu, Stefan[UCL] (1991) Annals of Hematology — Vol. 62, no. 2-3, p. 41-44 (1991)
    • Speech
    Comparability of Prostate Trials
    Suciu, Stefan[UCL] Sylvester, Richard J.[UCL] Iversen, P. Christensen, I. Denis, L. (1993) 3rd International Workshop on Randomized Trials on Maximal Androgen Blockade in M1 Prostate Cancer Patients — PARIS(France)
    • Journal article
    Expression of Mage Genes in Primary and Metastatic Cutaneous Melanoma
    Brasseur, Francis[UCL] Vanwijck, Romain[UCL] Humblet, Yves[UCL] Bourlond, André[UCL] Suciu, Stefan[UCL] Lachapelle, Jean-Marie[UCL] Boon, Thierry[UCL] (2004) International Journal of Cancer — Vol. 63, no. 3, p. 375-380 (2004)
    • Speech
    Intensive chemotherapy versus autologous or allogeneic stemcell transplantation for the treatment of patients with poor risk MDS and secondary AML-A joint study of the Eortc, Ebmt, Hovon, Swiss, Scandinavian and Gimema leukemia groups: A biomed-2 EU-project.
    deWitte, TM Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Anak, O Hagemeijer, Anne[UCL] Selleslag, D. Delforge, Michel[UCL] Belhabi, A Schouten, H Gratwohl, A. Aul, C Aivado, M Amadori, S. Muus, P. Tigaud, I. Jotterand-Bellomo, M Willemze, R. (1999) —
    • Journal article
    Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS
    de Witte, T. Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Verhoef, G. Labar, B. Archimbaud, E. Aul, C Selleslag, D. Wijermans, P Mandelli, F. Amadori, S. Jehn, U. Muus, P. Boogaerts, M. Zittoun, R Gratwohl, A. Zwierzina, H Hagemeijer, Anne[UCL] Willemze, R. (2001) Blood — Vol. 98, no. 8, p. 2326-2331 (2001)
    • Journal article
    Highlights and strategies of the EORTC Leukemia Group
    de Witte, T. Marie, JP Suciu, Stefan[UCL] Anak, O (2002) European Journal of Cancer — Vol. 38, p. S94-S99 (2002)
    • Journal article
    What can we learn from phase II adjuvant trials in melanoma?
    Keilholz, U Suciu, Stefan[UCL] Eggermont, AMM (2000) The British journal of cancer — Vol. 83, no. 1, p. 6-7 (2000)
    • Journal article
    The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA
    Keating, S de Witte, T. Suciu, Stefan[UCL] Willemze, R. Hayat, M. Labar, B. Resegotti, L Ferrini, PR Caronia, F Dardenne, M Solbu, G Petti, MC Vegna, ML Mandelli, F. Zittoun, RA (1998) British Journal of Haematology — Vol. 102, no. 5, p. 1344-1353 (1998)
    • Journal article
    Detection of residual disease in childhood acute lymphoblastic leukemia - Reply
    Cave, H. Suciu, Stefan[UCL] Vilmer, E (1999) New England Journal of Medicine — Vol. 340, no. 2, p. 153-154 (1999)
    • Speech
    Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - Allogeneic or autologous - Or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8A study
    Zittoun, R Suciu, Stefan[UCL] Solbu, G Watson, M. Muus, P. Mandelli, F. Stryckmans, P. Peetermans, M Thaler, J Willemze, R. (1995) —
    • Journal article
    Centre effect on treatment outcome for patients with untreated acute myelogenous leukaemia? An analysis of the AML 8A study of the Leukemia Cooperative Group of the EORTC and GIMEMA
    Keating, S de Witte, T. Suciu, Stefan[UCL] Mandelli, F. Damasio, E Willemze, R. Morra, E. Amadori, S. Dardenne, M Vegna, ML Zittoun, RA (1999) European Journal of Cancer — Vol. 35, no. 10, p. 1440-1447 (1999)
    • Journal article
    High tPA-expression in primary melanoma of the limb correlates with good prognosis
    Ferrier, CM Suciu, Stefan[UCL] van Geloof, WL Straatman, H Eggermont, AMM Koops, HS Kroon, BBR Lejeune, FJ Kleeberg, UR van Muijen, GNP Ruiter, DJ (2000) The British journal of cancer — Vol. 83, no. 10, p. 1351-1359 (2000)
    • Journal article
    Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma
    Kivela, T Humblet, Yves[UCL] Suciu, Stefan[UCL] Hansson, J Kruit, WHJ Vuoristo, MS Kloke, O Gore, M Hahka-Kemppinen, M Parvinen, LM Kumpulainen, E Pyrhonen, S (2003) European Journal of Cancer — Vol. 39, no. 8, p. 1115-1120 (2003)
    • Speech
    LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)
    Agarwala, Sanjiv S. Keilholz, Ulrich Gilles, Erard Bedikian, Agop Y. Wu, Jane Kay, Richard Stein, Cy A. Itri, Loretta M. Suciu, Stefan[UCL] Eggermont, Alexander M. M. (2009) 43rd Annual Meeting of the American-Society-of-Clinical-Oncology — Chicago(Il)
    • Journal article
    Value of allogeneic versus autologous stem cell transplantation and chemotherapy in patients with myelodysplastic syndromes and secondary acute myeloid leukemia. Final results of a prospective randomized European intergroup trial
    de Witte, Theo Hagemeijer, Anne Suciu, Stefan Belhabri, Amin Delforge, Michel Kobbe, Guido Selleslag, Dominik Schouten, Harry C. Ferrant, Augustin[UCL] Biersack, Harald Amadori, Sergio Muus, Petra Jansen, Joop H. Hellström-Lindberg, Eva Kovacsovics, Tibor Wijermans, Pierre Ossenkoppele, Gert Gratwohl, Alois Marie, Jean-Pierre Willemze, Roel (2010) Haematologica : the hematology journal — Vol. 95, no. 10, p. 1754-1761 (2010)